|
Company* |
Company* |
Product |
Terms/Details (Date) |
|
Albany |
Seattle Genetics Inc. (SGEN) |
Preferred provider agreement for the manufacture of Seattle Genetics' drug-linker system |
The deal secures rights for Seattle Genetics' licensees to work directly with AMRI on the manufacturing of drug-linker units; terms were not disclosed (7/13) |
|
Amgen Inc. |
NPS Pharmaceuticals Inc. (NPSP) |
NPS will promote Amgen's Kineret, a biologic therapy for rheumatoid arthritis, in the U.S. |
Amgen will supply product and support, and NPS will get a percentage of Kineret revenues; NPS will be the exclusive representative to rheumatologists (8/9) |
|
Arcturus |
Paradigm Genetics Inc. (PDGM) |
Paradigm Array Laboratories began offering services using Arcturus technology |
The technology involves microgenomics and laser-capture microdissection; terms were not disclosed (8/11) |
|
BioDiscovery Inc.* |
Bio-Rad Laboratories Inc. (AMEX:BIO) |
BioDiscovery software and its data analysis package will be incorporated into Bio-Rad microarray products | Bio-Rad will sell the products with its microarray scanner and arrayer equipment worldwide; terms were not disclosed (6/29) |
Cepheid |
Gene Co.* (Hong Kong) | Nonexclusive, three-year deal under which Gene Co. will distribute Cepheid's products in China and Hong Kong |
The products include SmartCycler Systems, accessories and OmniMix HS reagents; terms were not disclosed (7/13) |
|
CMC |
Resistentia AB* (Sweden) |
Development and manufacturing deal for a fusion protein for use in IgE-mediated allergies |
CMC will manufacture the product at its facility in Copenhagen; terms were not disclosed (9/15) |
|
Large Scale |
Planet Biotechnology Inc.* |
Deal to extract and purify Planet's CaroRx, a plant-made antibody to control dental caries |
Terms of the manufacturing agreement were not disclosed; the product has completed Phase I trials (7/15) |
|
LION Bioscience |
BioByte Corp.* and ChemNavigator Inc.* |
LION will incorporate Bio-Byte's calculation software into its LeadNavigator software |
ChemNavigator is providing software modules for integration into LeadNavigator; LION also agreed to resell ChemNavigator products and services; terms of the deals were not disclosed (8/24) |
|
Nonlinear |
Matrix Science Ltd.* (UK) |
Deal to develop integrated proteomics software products |
Nonlinear's protein informatics system will be integrated with Matrix's Mascot Server search engine; terms were not disclosed (8/9) |
|
Perlegen |
Affymetrix Inc. (AFFX) |
Deal to provide researchers access to custom genotyping services via Perlegen's high-throughput genotyping facility |
Affymetrix will market the service, which Perlegen will provide on a fee-for-service basis (7/6) |
|
Qiagen NV |
Evotec OAI AG (Germany; FSE:EVT) |
They agreed to promote the benefits of combining Qiagen's TOM-amidites RNAi products with Evotec's Opera platform |
The collaboration with Evotec's subsidiary, Evotec Technologies GmbH, is focused on providing functional gene analysis; terms were not disclosed (9/13) |
|
Rentschler |
Maxygen Inc. (MAXY) |
Deal for the scale-up and manufacture of Phase I and Phase II supplies for a Maxygen program |
The product is Maxygen's next-generation granulocyte-cell stimulating factor molecule; terms were not disclosed (9/9) |
|
Sirna |
Archemix Corp.* |
Four-year development and manufacturing alliance for all of Archemix's cGMP aptamers through Phase IIa trials |
Archemix also got a nonexclusive license to relevant intellectual property; the deal followed an October 2003 agreement under which Sirna manufactured an anti-thrombin aptamer (7/28) |
| | |||
Notes: | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
AMEX = American Stock Exchange; FSE = Frankfurt Stock Exchange, TSE = Toronto Stock Exchange. | |||
